macs monthly header with macs logo and graphic of medical professionals in training

The latest in substance use disorders and pain management education for healthcare providers

April 2023

Hello Anna,


Last Monday, March 27, SAMHSA released guidance on the MATE Act provision that requires prescribers of controlled substances to complete 8-hours of training on substance use disorders upon renewing or receiving their DEA license.


This guidance emphasized the importance of "incorporating training on substance use disorders into routine healthcare" and continuing to work collectively to address the overdose crisis. Below are a few pertinent details about the training requirement:


  • The 8-hours of training can be cumulative across multiple sessions
  • Trainings can occur in a variety of formats as long as the training is provided by or approved by the groups listed on the announcement
  • Past trainings on opioid or other substance use disorders, including the DATA 2000 waiver trainings, can count towards a DEA registrant’s 8-hour training requirement


MACS remains committed to supporting Maryland practitioners and their practices in addressing the needs of their patients with SUDs through training, consultation, and technical assistance. Our team will continue to keep you updated on policy changes that impact your practice.


To learn more about the SUD training requirement and frequently asked questions, click here or call 1-855-337-MACS.


-The MACS Team

EDUCATION

OTP ECHO

Reinstatement Protocols


Wednesday, April 5 | 12:30 - 1:45 pm

Register for cycle
noun_pregnant woman_710364-teal.png

MACS for MOMs ECHO Clinic

Stimulants and Benzodiazepines


Tuesday, April 11 | 8:00 - 9:00 am

Register for cycle
photo of youth smiling together

MACS & BHIPP Children's Mental Health Awareness Week Webinar

Addressing Youth Substance Use and Substance Use Disorder 

Friday, May 12 | 12:00 - 1:00 pm

Register
Photo of presenter, Randall Leonard, LCSW-C

Central East ATTC Webinar

Liberation Approaches in LGBTQ Behavioral Health (including substance use) & The Crossroads of Racial & Sexual/Gender Identity

Wednesday, April 5 | 1:00 - 3:00 pm

Register
image of clinicians at meeting

PCSS Clinical Roundtable

Xylazine and How it Harms People Who Use Drugs

Tuesday, April 11 | 3:00 - 4:00 pm

Register

Conferences & Presentations

ASAM Annual Conference: Innovations in Addiction Medicine and Science | MACS will be tabling

April 13 - 16 | National Harbor, MD

More info

UMB School of Nursing 6th Annual Symposium on Home and Community-Based Care | MACS Consultants Sarah Kattakuzhy and Aaron Greenblatt are presenting on harm reduction and OUD treatment options for home-bound patients

April 17 | University of Maryland Baltimore

More info

Maryland Society of Health System Pharmacy Spring Seminar | MACS team members will be tabling

April 21 | The Hotel at Arundel Preserve

More info

MAAPC & CBANACNS Pharmacology Update 2023 | MACS team members will be tabling

April 22 | Anne Arundel Community College

More info

NEWS

close up image of naloxone nasal spray

FDA approves over-the-counter Narcan. Here’s what it means


The FDA approved selling the overdose antidote naloxone over the counter on Wednesday, 3/29. Read more from STAT News...


According to an alert from the Maryland Opioid Operational Command Center, Marylanders can continue to obtain naloxone from pharmacies without a prescription due to the standing order and at no cost from overdose response programs.

Alcohol screening in primary care increased initial treatment but not longer-term engagement



The Sustained Patient-Centered Alcohol-Related Care trial was conducted in 22 primary care practices in an integrated health system in Washington state. This intervention resulted in increased alcohol screening but not engagement in treatment. Read more from ACP Internist...

Availability of Specific Programs and Medications for Addiction Treatment to Vulnerable Populations: Results from the Addiction Treatment Locator, Assessment, and Standards (ATLAS) Survey


"This study aimed to describe addiction treatment facilities by their offerings of medications for alcohol use disorder (MAUD) and/or for opioid use disorder (MOUD), and by their offering services to groups with barriers to care." Read more from Journal of Addiction Medicine...

‘Zombie drug’ challenging response to Maryland opioid crisis


The Maryland Department of Health Center for Harm Reduction Services partnered with the National Institute of Standards and Technology to test drugs in Maryland to stay informed about novel psychoactive substances in the illicit drug market. MACS Consultant and CHRS Medical Director, Dr. Malik Burnett, is interviewed in this article. Read more from Maryland Matters...

Universal Precautions for People at Risk of Opioid Overdose in North America

Read more from JAMA...

Doctor Who Battled Addiction Helps Peers Do the Same

Read more from the Harvard Gazette...

Hear from Your Peers

video of MACS participant, Laura Sheely, CRNP, as she shares about her experience with MACS services

MACS participant and NP, Laura Sheeley, shares about her experience with MACS services.

Holiday

MACS Phone Line Will Be Closed:

May 29 - Memorial Day

April Observances

Alcohol Awareness Month

Minority Health Month

Public Health Week

April 3 - 9

Black Maternal Health Week

April 11 - 17

Osteopathic Medicine Week

April 19 - 25

Drug Takeback Day

April 29

Follow us to stay connected:

Facebook  LinkedIn  Twitter  Instagram

RESOURCES

provider talking to patient

Helping Your Patients with Alcohol-Related Problems

collage of colorful arms creating a heart

Cultural Competence and Integrated Care for Substance Use Disorders

SAMHSA is Alerting Providers and Grantees About the Risks of Xylazine

title of toolkit with blue and orange and beige background

Improving Linkages to Comprehensive Care for People at Risk of Overdose Toolkit

Trauma-informed, Resilience-oriented, Equity-focused Systems (TIROES) National Learning Community

Building Cultural Intelligence and Health Equity in Behavioral Health

LinkedIn Share

Follow us:

Facebook  Twitter  LinkedIn  Instagram  YouTube